SCHEMBL21361324

SCHEMBL21361324

CCc1cc(C(=O)N(C)OC)ccc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.43
HSP90AA1 P07900 3/20 0.43
HSP90AB1 P08238 3/20 0.43
HPGD P15428 1/20 0.42
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 1/20 0.37
BLM P54132 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
SLC6A3 Q01959 1/20 0.35
POLB P06746 1/20 0.34
RECQL P46063 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17894222 0.89 MLYCD (0.42) MLYCDHSP90AA1HSP90AB1HPGDMEN1
SCHEMBL256775 0.88 MLYCD (0.41) MLYCDHSP90AA1HSP90AB1HPGDMEN1
SCHEMBL18348146 0.83 HSP90AA1 (0.47) HSP90AA1HSP90AB1HPGDMEN1KMT2A
SCHEMBL25257215 0.81 MLYCD (0.36) MLYCDHSP90AA1HSP90AB1HPGDMEN1
SCHEMBL2272338 0.81 MLYCD (0.45) MLYCDHPGDMEN1KMT2AHTT
SCHEMBL17893862 0.81 TSHR (0.46) MLYCDHSP90AA1HSP90AB1HPGDMEN1
SCHEMBL26566639 0.80 MLYCD (0.36) MLYCDHSP90AA1HSP90AB1HPGDMEN1
SCHEMBL589423 0.79 MLYCD (0.48) MLYCDHPGDMEN1KMT2AHTT
SCHEMBL3706341 0.79 MEN1 (0.58) MLYCDHSP90AA1HSP90AB1HPGDMEN1
SCHEMBL25256351 0.79 MLYCD (0.38) MLYCDHSP90AA1HSP90AB1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018011-B2 Macrocyclic compounds and compositions, and methods of preparing and using the same KURA ONCOLOGY, INC. (US) 2024-06-25 US disclosed
US-20230322711-A1 MACROCYCLIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF PREPARING AND USING THE SAME WUXI APPTEC (HONG KONG) LIMITED (CN) 2023-10-12 US disclosed
US-20220106323-A1 SPIROCYCLIC ROR-GAMMA MODULATORS ESCALIER BIOSCIENCES B.V. 2022-04-07 US disclosed
US-20220106329-A1 BICYCLIC ROR-GAMMA MODULATORS ESCALIER BIOSCIENCES B V (US) 2022-04-07 US disclosed
US-11242350-B2 Spirocyclic ROR-gamma modulators ESCALIER BIOSCIENCES B.V. (US) 2022-02-08 US disclosed
US-11230555-B2 Bicyclic RORγ modulators ESCALIER BIOSCIENCES B.V. (US) 2022-01-25 US disclosed
US-20210053987-A1 BICYCLIC ROR-GAMMA MODULATORS ESCALIER BIOSCIENCES B.V. 2021-02-25 US disclosed
US-20210053976-A1 SPIROCYCLIC ROR-GAMMA MODULATORS ESCALIER BIOSCIENCES B.V. 2021-02-25 US disclosed
CN-112292124-A Bicyclic ROR-gamma modulators 爱思凯利尔生物科学私人有限责任公司 2021-01-29 CN disclosed
CN-112118841-A Spirocyclic ROR-gamma modulators 爱思凯利尔生物科学私人有限责任公司 2020-12-22 CN disclosed
WO-2019177997-A1 SPIROCYCLIC ROR-GAMMA MODULATORS ESCALIER BIOSCIENCES B.V. (US) 2019-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11242350-B2 Spirocyclic ROR-gamma modulators RORA, RORC, RORB MLYCD 4092/4885HSP90AA1 854/4885HSP90AB1 830/4885
US-12018011-B2 Macrocyclic compounds and compositions, and methods of preparing and using the same FNTA, FDPS, GGPS1 MLYCD 1364/4885HSP90AA1 2438/4885HSP90AB1 2585/4885
US-20230322711-A1 MACROCYCLIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF PREPARING AND USING THE SAME FNTA, FDPS, GGPS1 MLYCD 1364/4885HSP90AA1 2438/4885HSP90AB1 2585/4885
US-11230555-B2 Bicyclic RORγ modulators RORC, RORA, RORB MLYCD 3627/4885HSP90AA1 1901/4885HSP90AB1 1680/4885
US-20210053987-A1 BICYCLIC ROR-GAMMA MODULATORS RORA, RORC, RORB MLYCD 3583/4885HSP90AA1 1903/4885HSP90AB1 1768/4885
US-20220106323-A1 SPIROCYCLIC ROR-GAMMA MODULATORS RORA, RORC, RORB MLYCD 4092/4885HSP90AA1 854/4885HSP90AB1 830/4885
US-20210053976-A1 SPIROCYCLIC ROR-GAMMA MODULATORS RORA, RORC, RORB MLYCD 4180/4885HSP90AA1 649/4885HSP90AB1 693/4885
US-20220106329-A1 BICYCLIC ROR-GAMMA MODULATORS RORA, RORC, RORB MLYCD 3583/4885HSP90AA1 1903/4885HSP90AB1 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.